An NIH study of treatments for high blood pressure, called the ALLHAT trial, shows some of the strengths and limitations of comparative effectiveness research to improve patient care. More...
A recent article by Jerome Groopman, M.D, provides some valuable, first-hand insight as to what can go wrong when policy makers “give teeth” to comparative effectiveness research (CER) studies by translating results into “best practices.” Groopman’s understanding of the limitations of CER and the complexities of delivery high quality care to each patient, lead him to caution against blunt application of CER in ways that do not give physicians the ability to deviat
Agree or disagree with the recent changes to mammography guidelines by the U.S. Preventive Services Task Force (USPSTF), one thing is clear – two sets of highly qualified experts can come to very different conclusions when looking at the same evidence. This holds big implications for provisions of health care reform like comparative effectiveness research (CER).
Tony Coelho, chairman of the Partnership to Improve Patient Care (PIPC), praised the Administration’s commitment to advancing patient-centered comparative effectiveness research, and urged...
WASHINGTON, DC - The Partnership to Improve Patient Care (PIPC), a non-partisan, patient- focused, grassroots organization focused on securing patient-centered comparative effectiveness research (...
WASHINGTON, June 26, 2009 – After speaking at a health care reform event on comparative effectiveness research and choice in health care, Chairman of the Partnership to Improve...